FDA inspection
Pfizer Inc.: FDA inspection ending Aug 10, 2009
FDA inspection 606526 · Official Action Indicated (OAI) · New York, NY
Key facts
| Inspection ID | 606526 |
|---|---|
| Firm | Pfizer Inc. |
| FEI number | 2416101 |
| Address | 235 East 42nd Street |
| City | New York |
| State | NY |
| ZIP | 10017 |
| Country | United States |
| Fiscal year | 2009 |
| Inspection end date | Aug 10, 2009 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
| Warning letter | 79704 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data